Ricardo Perez, MD
Family Medicine · Bayamon, PRNPI 1144280108
Payments from drug & device makers
Across 31 payments — averaging $39.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$351
- Boston Scientific$247
- Johnson & Johnson$229
- AstraZeneca$124
- GSK$90
- Merck$73
- plus $113 from 4 others
What the payments were for
- Food & beverage$1,226100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 4 | $351 |
| Boston Scientific | 7 | $247 |
| Johnson & Johnson | 4 | $229 |
| AstraZeneca | 7 | $124 |
| GSK | 1 | $90 |
| Merck | 3 | $73 |
| PBG Puerto Rico LLC | 2 | $40 |
| Boehringer Ingelheim | 1 | $32 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| Medtronic | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN Access System$112
- Mavyret$108
- XARELTO$102
How this compares
$1,226 in reported general payments places this provider in the 80th percentile of 497 family medicine providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 76 | $120,340 |
| TrulicityDulaglutide | 54 | $68,148 |
| Trijardy XrEmpaglifloz/Linaglip/Metformin | 50 | $67,649 |
| SynthroidLevothyroxine Sodium | 320 | $39,967 |
| GlyxambiEmpagliflozin/Linagliptin | 21 | $35,419 |
| JanuviaSitagliptin Phosphate | 25 | $34,686 |
| EliquisApixaban | 23 | $33,610 |
| FarxigaDapagliflozin Propanediol | 17 | $24,578 |
| XareltoRivaroxaban | 21 | $22,379 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 17 | $20,846 |
| JanumetSitagliptin Phos/Metformin Hcl | 14 | $17,233 |
| TradjentaLinagliptin | 11 | $15,770 |
| SynjardyEmpagliflozin/Metformin Hcl | 13 | $11,627 |
| LantusInsulin Glargine,hum.Rec.Anlog | 48 | $7,487 |
| Losartan Potassium | 459 | $7,157 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Trijardy Xr, Glyxambi, Synjardy Xr, Tradjenta | $32 | $271,651188 claims |
| MerckJanuvia, Janumet | $73 | $51,91939 claims |
| AbbVieSynthroid | $351 | $39,967320 claims |
| AstraZenecaFarxiga | $124 | $24,57817 claims |
| Johnson & JohnsonXarelto | $229 | $22,37921 claims |
| Sanofi-aventis U.S. LLCLantus | $25 | $7,48748 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 497 family medicine providers in Puerto Rico.
Other family medicine in Bayamon
- Marcelino Cintron PontonBayamon$3K
- Eddie Ortiz RiveraBayamon$3K
- Veronica Perez RamosBayamon$2K
- Jorge MeauxBayamon$2K
- Carmen CabreraBayamon$2K
- Kathy Caraballo RiveraBayamon$2K
- Raymond Tasch RamirezBayamon$2K
- Lizette Santiago ColonSan Juan$1.5M
- Carlos SariolSan Juan$1.4M
- Ivan Melendez-RiveraPonce$311K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.